Sun Pharma Eyes Organon In What Could Be India Pharma’s Biggest Cross-Border Deal: Report
India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE:OGN), a U.S.-based women’s healthcare company. If it goes through, the deal that could become the largest cross-border transaction ever by an Indian drugmaker, according to people familiar with the matter, as cited by The Economic Times. Sun Pharmaceutical has […]
Rio Tinto, Glencore Merger Could Trigger A Significant Asset Spin-Off
Rio Tinto Plc (NYSE:RIO) and Glencore Plc (OTC:GLCNF) are weighing a potential spin-off of coal assets. Despite initial optimism, coal remains one of the complex obstacles to combining two vastly different portfolios and investor bases under one roof. Thus, moving those assets in a separately listed Australian vehicle is one of the discussion points amidst […]
Potential Mining Superdeal Leaves A Mixed Reaction
Heavyweight miners Glencore (OTC:GLCNF) and Rio Tinto (NYSE:RIO) made headlines last week after confirming early-stage talks about the mega merger. The $200 billion deal, which has eluded the market for nearly two decades, now looks closer than ever. Glencore chief executive Gary Nagle has previously described a combination with Rio as “the most obvious deal […]
What’s Going With Cancer Biotech Erasca Stock On Thursday?
Erasca Inc. (NASDAQ:ERAS) shares on Wednesday jumped close to 60% to $6.12. On Thursday, the stock fell as low as $4.33. • Erasca shares are advancing steadily. Why is ERAS stock trading higher? The movement came in reaction to a rumored deal, wherein AbbVie Inc. (NYSE:ABBV) was reportedly in advanced talks to buy cancer-drug biotech […]
Nvidia Eyes Another Talent-Focused Acquisition: Report
NVIDIA Corp. (NASDAQ:NVDA) is reportedly in advanced discussions for another M&A deal aimed at acquiring talent, as it faces pressure from Google‘s internal chip development. NVDA stock is moving. See the chart and price action here. A Focus on Talent Nvidia is negotiating a deal to buy AI21 Labs in a transaction estimated to be […]
Silver Rallies After Worst Day In 5 Years — Metals Bounce Back
Silver futures, tracked by the iShares Silver Trust (NYSE:SLV), staged a recovery on Tuesday, following Monday’s historic plunge which marked the sharpest single-day decline in five years. SLV shares are climbing. See the chart and price action here. The white metal, which has outshone almost every other asset class in 2025, found support as buyers […]
Metals Acting Like Meme Stocks—Unconfirmed Rumor Of Major Silver Margin Call
The “Hard Asset Super-Cycle” of 2025 hit a speed bump on Monday, as a wave of profit-taking and easing geopolitical tensions triggered a sharp year-end correction across the metals complex. There was also a viral and unconfirmed rumor of a massive silver margin call circulating on social media, possibly adding to the downward turn. The […]
What’s Happening With French Biotech Abivax Stock On Wednesday?
Abivax SA’s (NASDAQ:ABVX) stock is trading higher on Wednesday. The stock reacted to market rumours that U.S. pharma giant Eli Lilly and Co (NYSE:LLY) could make an offer. • Abivax stock is charging ahead with explosive momentum. Check out ABVX shares here. The “share price movement is driven by speculation around a possible takeover,” Stifel […]
Elon Musk’s Team Reacts After Starlink’s Unexpected India Pricing Leak Goes Live — Calls It A ‘Config Glitch’ As Approval Wait Continues
Elon Musk‘s satellite internet company Starlink clarified Monday that subscription fees for its service in India have not been set and orders are not open, following a brief website glitch that showed dummy pricing. The company’s website earlier showed a subscription fee for residential satellite internet service in India as ₹8,600 (about $95) per month, […]
UnitedHealth Unwinds Last South America Asset In $1 Billion Banmedica Sale
UnitedHealth Group (NYSE:UNH) has reportedly reached a $1 billion agreement to sell its remaining South American operation, Banmedica, to Brazilian private equity firm Patria Investments. The move reflects the company’s broader push to streamline operations and support its ongoing turnaround efforts under CEO Stephen Hemsley. Citing people familiar with the negotiations, Reuters noted that the […]